United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - lamotrigine - dispersible tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - lamotrigine - dispersible tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - lamotrigine - dispersible tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

stephar (u.k.) ltd - lamotrigine - dispersible tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - lamotrigine - dispersible tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cst pharma ltd - lamotrigine - dispersible tablet - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cst pharma ltd - lamotrigine - dispersible tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - lamotrigine - dispersible tablet - 5mg

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lamotrigine, quantity: 5 mg - tablet - excipient ingredients: calcium carbonate; hyprolose; aluminium magnesium silicate; sodium starch glycollate; povidone; saccharin sodium; magnesium stearate; flavour - lamictal is an anti-epileptic drug for the treatment of partial and generalised seizures in adults and children. there is extensive experience with lamictal used initially as ?add-on? therapy. the use of lamictal has also been found to be effective as monotherapy following withdrawal of concomitant anti-epileptic drugs. initial monotherapy treatment in newly diagnosed paediatric patients is not recommended (see clinical trials). lamictal is indicated for the prevention of depressive episodes in patients with bipolar disorder.

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - lamotrigine - chewable/dispersible tablet - 2 milligram(s) - other antiepileptics; lamotrigine